Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

Pleomorphic xanthoastrocytoma: long-term results of surgical treatment and analysis of prognostic factors.

Gallo P, Cecchi PC, Locatelli F, Rizzo P, Ghimenton C, Gerosa M, Pinna G.

Br J Neurosurg. 2013 Dec;27(6):759-64. doi: 10.3109/02688697.2013.776666. Epub 2013 Mar 20.

PMID:
23514331
2.

Clinical outcome of surgically treated low-grade gliomas: a retrospective analysis of a single institute.

Turkoglu E, Gurer B, Sanli AM, Dolgun H, Gurses L, Oral NA, Donmez T, Sekerci Z.

Clin Neurol Neurosurg. 2013 Dec;115(12):2508-13. doi: 10.1016/j.clineuro.2013.10.010. Epub 2013 Oct 25.

PMID:
24225484
3.

Patterns of care and outcomes of patients with pleomorphic xanthoastrocytoma: a SEER analysis.

Perkins SM, Mitra N, Fei W, Shinohara ET.

J Neurooncol. 2012 Oct;110(1):99-104. doi: 10.1007/s11060-012-0939-8. Epub 2012 Jul 28.

PMID:
22843450
4.

Temporal lobe pleomorphic xanthoastrocytoma and chronic epilepsy: long-term surgical outcomes.

Wallace DJ, Byrne RW, Ruban D, Cochran EJ, Roh D, Whisler WW.

Clin Neurol Neurosurg. 2011 Dec;113(10):918-22. doi: 10.1016/j.clineuro.2011.06.001. Epub 2011 Jul 7.

PMID:
21741164
5.

Efficacy of prognostic factors on survival in patients with low grade glioma.

Durmaz R, Vural M, Işildi E, Coşan E, Ozkara E, Bal C, Ciftçi E, Arslantaş A, Atasoy MA.

Turk Neurosurg. 2008 Oct;18(4):336-44.

6.

Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas.

McGirt MJ, Chaichana KL, Attenello FJ, Weingart JD, Than K, Burger PC, Olivi A, Brem H, Quinoñes-Hinojosa A.

Neurosurgery. 2008 Oct;63(4):700-7; author reply 707-8. doi: 10.1227/01.NEU.0000325729.41085.73.

PMID:
18981880
7.

Early prognostic factors related to progression and malignant transformation of low-grade gliomas.

Jung TY, Jung S, Moon JH, Kim IY, Moon KS, Jang WY.

Clin Neurol Neurosurg. 2011 Nov;113(9):752-7. doi: 10.1016/j.clineuro.2011.08.002. Epub 2011 Sep 1.

PMID:
21889256
8.

Factors associated with progression-free survival and long-term neurological outcome after resection of intramedullary spinal cord tumors: analysis of 101 consecutive cases.

Garcés-Ambrossi GL, McGirt MJ, Mehta VA, Sciubba DM, Witham TF, Bydon A, Wolinksy JP, Jallo GI, Gokaslan ZL.

J Neurosurg Spine. 2009 Nov;11(5):591-9. doi: 10.3171/2009.4.SPINE08159.

PMID:
19929363
9.

Proposed therapeutic strategy for adult low-grade glioma based on aggressive tumor resection.

Nitta M, Muragaki Y, Maruyama T, Ikuta S, Komori T, Maebayashi K, Iseki H, Tamura M, Saito T, Okamoto S, Chernov M, Hayashi M, Okada Y.

Neurosurg Focus. 2015 Jan;38(1):E7. doi: 10.3171/2014.10.FOCUS14651.

PMID:
25599276
10.

Malignant progression in pleomorphic xanthoastrocytoma: personal experience and review of the literature.

Marton E, Feletti A, Orvieto E, Longatti P.

J Neurol Sci. 2007 Jan 31;252(2):144-53. Epub 2006 Dec 26. Review.

PMID:
17189643
11.

Prognostic factors and treatment options for paediatric ependymomas.

Vaidya K, Smee R, Williams JR.

J Clin Neurosci. 2012 Sep;19(9):1228-35. doi: 10.1016/j.jocn.2012.02.006. Epub 2012 Jul 25.

PMID:
22840355
12.

Pleomorphic xanthoastrocytoma in children and adolescents.

Rao AA, Laack NN, Giannini C, Wetmore C.

Pediatr Blood Cancer. 2010 Aug;55(2):290-4. doi: 10.1002/pbc.22490.

PMID:
20582976
13.

Pleomorphic xanthoastrocytoma: what do we really know about it?

Giannini C, Scheithauer BW, Burger PC, Brat DJ, Wollan PC, Lach B, O'Neill BP.

Cancer. 1999 May 1;85(9):2033-45.

PMID:
10223246
14.

BRAF mutation and anaplasia may be predictive factors of progression-free survival in adult pleomorphic xanthoastrocytoma.

Tabouret E, Bequet C, Denicolaï E, Barrié M, Nanni I, Metellus P, Dufour H, Chinot O, Figarella-Branger D.

Eur J Surg Oncol. 2015 Dec;41(12):1685-90. doi: 10.1016/j.ejso.2015.09.012. Epub 2015 Sep 30.

PMID:
26454767
15.

Prognostic Factors in Lobar World Health Organization Grade II Astrocytomas.

Waqar M, Hanif S, Brodbelt AR, Rathi N, Das K, Zakaria R, Walker C, Jenkinson MD.

World Neurosurg. 2015 Jul;84(1):154-62. doi: 10.1016/j.wneu.2015.02.045. Epub 2015 Mar 14.

PMID:
25779854
16.

The assessment of prognostic factors in surgical treatment of low-grade gliomas: a prospective study.

Majchrzak K, Kaspera W, Bobek-Billewicz B, Hebda A, Stasik-Pres G, Majchrzak H, Ładziński P.

Clin Neurol Neurosurg. 2012 Oct;114(8):1135-44. doi: 10.1016/j.clineuro.2012.02.054. Epub 2012 Mar 17.

PMID:
22425370
17.

Independent association of extent of resection with survival in patients with malignant brain astrocytoma.

McGirt MJ, Chaichana KL, Gathinji M, Attenello FJ, Than K, Olivi A, Weingart JD, Brem H, Quiñones-Hinojosa AR.

J Neurosurg. 2009 Jan;110(1):156-62. doi: 10.3171/2008.4.17536.

PMID:
18847342
18.

Pleomorphic xanthoastrocytomas: institutional experience of 18 patients.

Oh T, Kaur G, Madden M, Bloch O, Parsa AT.

J Clin Neurosci. 2014 Oct;21(10):1767-72. doi: 10.1016/j.jocn.2014.04.002. Epub 2014 Jun 17.

PMID:
24950906
19.

Adult intracranial WHO grade II ependymomas: long-term outcome and prognostic factor analysis in a series of 114 patients.

Metellus P, Guyotat J, Chinot O, Durand A, Barrie M, Giorgi R, Jouvet A, Figarella-Branger D.

Neuro Oncol. 2010 Sep;12(9):976-84. doi: 10.1093/neuonc/noq047. Epub 2010 May 19.

20.

[Pleomorphic xanthoastrocytoma: clinical symptoms, treatment, outcome].

Majchrzak K, Bierzyńska-Macyszyn G, Ładziński P.

Neurol Neurochir Pol. 2003 May-Jun;37(3):611-9. Polish.

PMID:
14593756

Supplemental Content

Support Center